Preclinical Dose Ranging Studies of a Novel Dry Powder Norovirus Vaccine Formulation

Norovirus is the primary cause of viral gastroenteritis in humans with multiple genotypes currently circulating worldwide. The development of a successful norovirus vaccine is contingent on its ability to induce both systemic and mucosal antibody responses against a wide range of norovirus genotypes...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Vaccine
Egile Nagusiak: Springer, Michael J., Ni, Yawei, Finger-Baker, Isaac, Ball, Jordan P., Hahn, Jessica, DiMarco, Ashley V., Kobs, Dean, Horne, Bobbi, Talton, James D., Cobb, Ronald R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4775331/
https://ncbi.nlm.nih.gov/pubmed/26873053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.01.064
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak